International Medicine and Health Guidance News ›› 2023, Vol. 29 ›› Issue (20): 2825-2828.DOI: 10.3760/cma.j.issn.1007-1245.2023.20.001
• New Medical Advances • Next Articles
Research progress of GSDMD-mediated pyrodeath in atrial fibrillation
Shang Xue, Zhao Jiahao, Li Xinxi, Zhu Hui, Zhao Ke, Liu Zhenxing, Xu Huipu
Department of Cardiovascular Medicine, Binzhou Medical University Hospital, Binzhou 256600, China
Received:
2023-05-09
Online:
2023-10-15
Published:
2023-11-06
Contact:
Xu Huipu, Email: xuhuipu1967@163.com
Supported by:
Pyrocytosis; Atrial fibrillation; GSDMD; Progress
GSDMD介导的细胞焦亡在心房颤动中的研究进展
商雪 赵嘉昊 李昕玺 祝慧 赵珂 刘振兴 徐会圃
滨州医学院附属医院心血管内科,滨州 256600
通讯作者:
徐会圃,Email:xuhuipu1967@163.com
基金资助:
山东省自然科学基金 (2014ZRB14275)
Shang Xue, Zhao Jiahao, Li Xinxi, Zhu Hui, Zhao Ke, Liu Zhenxing, Xu Huipu.
Research progress of GSDMD-mediated pyrodeath in atrial fibrillation [J]. International Medicine and Health Guidance News, 2023, 29(20): 2825-2828.
商雪 赵嘉昊 李昕玺 祝慧 赵珂 刘振兴 徐会圃.
GSDMD介导的细胞焦亡在心房颤动中的研究进展 [J]. 国际医药卫生导报, 2023, 29(20): 2825-2828.
Add to citation manager EndNote|Ris|BibTeX
URL: http://www.imhgn.com/EN/10.3760/cma.j.issn.1007-1245.2023.20.001
[1] Wang X, Fu Q, Song F, et al. Prevalence of atrial fibrillation in different socioeconomic regions of China and its association with stroke: results from a national stroke screening survey[J]. Int J Cardiol, 2018 ,271:92-97. DOI: 10.1016/j.ijcard.2018.05.131. [2] Chua W, Law JP, Cardoso VR, et al. Quantification of fibroblast growth factor 23 and N-terminal pro-B-type natriuretic peptide to identify patients with atrial fibrillation using a high-throughput platform: a validation study[J]. PLoS Med, 2021 ,18(2):e1003405. DOI: 10.1371/journal.pmed.1003405. [3] Wang X, Fu Q, Song F, et al. Prevalence of atrial fibrillation in different socioeconomic regions of China and its association with stroke: Results from a national stroke screening survey[J]. Int J Cardiol, 2018 ,271:92-97. DOI: 10.1016/j.ijcard.2018.05.131. [4] 王一斐,张萍. 心房颤动与炎症反应之交互关系[J]. 中国心血管杂志,2023,28(1):62-66. DOI:10.3969/j.issn.1007-5410.2023.01.013. [5] Chang G, Chen Y, Liu Z,et al. The PD-1 with PD-L1 axis is pertinent with the immune modulation of atrial fibrillation by regulating T cell excitation and promoting the secretion of inflammatory factors[J]. J Immunol Res, 2022 ,2022:3647817. DOI: 10.1155/2022/3647817. [6] Yao C, Veleva T, Scott L, et al. Enhanced cardiomyocyte NLRP3 inflammasome signaling promotes atrial fibrillation[J]. Circulation, 2018,138(20):2227-2242. DOI: 10.1161/CIRCULATIONAHA.118.035202. [7] 李彬,李泱,陈雅婷,等. 核苷酸结合寡聚化结构域样受体蛋白3炎性小体在肥胖相关心房颤动发病中的研究进展[J]. 中华老年心脑血管病杂志,2023,25(1):99-101. DOI:10.3969/j.issn.1009-0126.2023.01.026. [8] 谢红英,张小群,罗晓丽,等. Nod样受体蛋白3与非瓣膜性心房颤动患者左心房血栓形成的相关性[J]. 中华老年心脑血管病杂志,2019,21(10):1036-1040. DOI:10.3969/j.issn.1009-0126.2019.10.008. [9] Zychlinsky A, Prevost MC, Sansonetti PJ. Shigella flexneri induces apoptosis in infected macrophages[J]. Nature,1992,358(6382):167-169. DOI: 10.1038/358167a0. [10] Frank D, Vince JE. Pyroptosis versus necroptosis: similarities, differences, and crosstalk[J]. Cell Death Differ, 2019 ,26(1):99-114. DOI: 10.1038/s41418-018-0212-6. [11] Shi J, Zhao Y, Wang K, et al. Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death[J]. Nature, 2015 ,526(7575):660-665. DOI: 10.1038/nature15514. [12] Galluzzi L, Vitale I, Aaronson SA, et al. Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018[J]. Cell Death Differ, 2018 ,25(3):486-541. DOI: 10.1038/s41418-017-0012-4. [13] Shi J, Gao W, Shao F. Pyroptosis: gasdermin-mediated programmed necrotic cell death[J]. Trends Biochem Sci, 2017 ,42(4):245-254. DOI: 10.1016/j.tibs.2016.10.004. [14] Fang Y, Tian S, Pan Y, et al. Pyroptosis: a new frontier in cancer[J]. Biomed Pharmacother, 2020 ,121:109595. DOI: 10.1016/j.biopha.2019.109595. [15] 梅旦,张玲玲,魏伟. 细胞焦亡机制及与疾病的关系[J]. 生理科学进展,2020,51(2):151-156. DOI:10.3969/j.issn.0559-7765.2020.02.018. [16] Wang Y, Gao W, Shi X, et al. Chemotherapy drugs induce pyroptosis through caspase-3 cleavage of a gasdermin[J]. Nature, 2017 ,547(7661):99-103. DOI: 10.1038/nature22393. [17] Donado CA, Cao AB, Simmons DP, et al. A two-cell model for IL-1β release mediated by death-receptor signaling[J]. Cell Rep, 2020 ,31(1):107466. DOI: 10.1016/j.celrep.2020.03.030. [18] Demarco B, Grayczyk JP, Bjanes E, et al. Caspase-8-dependent gasdermin D cleavage promotes antimicrobial defense but confers susceptibility to TNF-induced lethality[J]. Sci Adv, 2020 ,6(47):eabc3465. DOI: 10.1126/sciadv.abc3465. [19] Zhou Z, He H, Wang K, et al. Granzyme A from cytotoxic lymphocytes cleaves GSDMB to trigger pyroptosis in target cells[J]. Science, 2020 ,368(6494):eaaz7548. DOI: 10.1126/science.aaz7548. [20] Zhang Z, Zhang Y, Xia S, et al. Gasdermin E suppresses tumour growth by activating anti-tumour immunity[J]. Nature, 2020 ,579(7799):415-420. DOI: 10.1038/s41586-020-2071-9. [21] Tamura M, Tanaka S, Fujii T, et al. Members of a novel gene family, Gsdm, are expressed exclusively in the epithelium of the skin and gastrointestinal tract in a highly tissue-specific manner[J]. Genomics, 2007 ,89(5):618-629. DOI: 10.1016/j.ygeno.2007.01.003. [22] Liu Z, Wang C, Yang J, et al. Crystal structures of the full-length murine and human gasdermin D reveal mechanisms of autoinhibition, lipid binding, and oligomerization[J]. Immunity, 2019 ,51(1):43-49.e4. DOI: 10.1016/j.immuni.2019.04.017. [23] He WT, Wan H, Hu L, et al. Gasdermin D is an executor of pyroptosis and required for interleukin-1β secretion[J]. Cell Res, 2015 ,25(12):1285-1298. DOI: 10.1038/cr.2015.139. [24] Xia S, Hollingsworth LR 4th, Wu H. Mechanism and regulation of gasdermin-mediated cell death[J]. Cold Spring Harb Perspect Biol, 2020 ,12(3):a036400. DOI: 10.1101/cshperspect.a036400. [25] Rodríguez-Antonio I, López-Sánchez GN, Uribe M, et al. Role of the inflammasome, gasdermin D, and pyroptosis in non-alcoholic fatty liver disease[J]. J Gastroenterol Hepatol, 2021 ,36(10):2720-2727. DOI: 10.1111/jgh.15561. [26] Hu S, Wang L, Xu Y, et al. Disulfiram attenuates hypoxia-induced pulmonary hypertension by inhibiting GSDMD cleavage and pyroptosis in HPASMCs[J]. Respir Res, 2022 ,23(1):353. DOI: 10.1186/s12931-022-02279-0. [27] Hu JJ, Liu X, Xia S, et al. FDA-approved disulfiram inhibits pyroptosis by blocking gasdermin D pore formation[J]. Nat Immunol, 2020 ,21(7):736-745. DOI: 10.1038/s41590-020-0669-6. [28] Lippi G, Sanchis-Gomar F, Cervellin G. Global epidemiology of atrial fibrillation: an increasing epidemic and public health challenge[J]. Int J Stroke, 2021 ,16(2):217-221. DOI: 10.1177/1747493019897870. [29] Mukherjee K, Kamal KM. Impact of atrial fibrillation on inpatient cost for ischemic stroke in the USA[J]. Int J Stroke, 2019 ,14(2):159-166. DOI: 10.1177/1747493018765491. [30] Leonelli Fabio,Bagliani Giuseppe,Boriani Giuseppeet al. Arrhythmias Originating in the Atria.[J] .Card Electrophysiol Clin, 2017, 9: 383-409. [31] Harada M, Nattel S. Implications of inflammation and fibrosis in atrial fibrillation pathophysiology[J]. Card Electrophysiol Clin, 2021 ,13(1):25-35. DOI: 10.1016/j.ccep.2020.11.002. [32] Yan B, Liu T, Yao C, et al. LncRNA XIST shuttled by adipose tissue-derived mesenchymal stem cell-derived extracellular vesicles suppresses myocardial pyroptosis in atrial fibrillation by disrupting miR-214-3p-mediated Arl2 inhibition[J]. Lab Invest, 2021 ,101(11):1427-1438. DOI: 10.1038/s41374-021-00635-0. [33] Chen G, Chelu MG, Dobrev D, et al. Cardiomyocyte inflammasome signaling in cardiomyopathies and atrial fibrillation: mechanisms and potential therapeutic implications[J]. Front Physiol, 2018 ,9:1115. DOI: 10.3389/fphys.2018.01115. [34] Yan B, Liu T, Yao C, et al. LncRNA XIST shuttled by adipose tissue-derived mesenchymal stem cell-derived extracellular vesicles suppresses myocardial pyroptosis in atrial fibrillation by disrupting miR-214-3p-mediated Arl2 inhibition[J]. Lab Invest, 2021 ,101(11):1427-1438. DOI: 10.1038/s41374-021-00635-0. [35] Li N, Brundel BJJM. Inflammasomes and proteostasis novel molecular mechanisms associated with atrial fibrillation[J]. Circ Res, 2020 ,127(1):73-90. DOI: 10.1161/CIRCRESAHA.119.316364. [36] Heijman J, Muna AP, Veleva T, et al. Atrial myocyte NLRP3/CaMKII nexus forms a substrate for postoperative atrial fibrillation[J]. Circ Res, 2020 ,127(8):1036-1055. DOI: 10.1161/CIRCRESAHA.120.316710. [37] Song L, Pei L, Yao S, et al. NLRP3 inflammasome in neurological diseases, from functions to therapies[J]. Front Cell Neurosci, 2017 ,11:63. DOI: 10.3389/fncel.2017.00063. [38] Shen HH, Yang YX, Meng X, et al. NLRP3: a promising therapeutic target for autoimmune diseases[J]. Autoimmun Rev, 2018 ,17(7):694-702. DOI: 10.1016/j.autrev.2018.01.020. [39] Wei X, Xie F, Zhou X, et al. Role of pyroptosis in inflammation and cancer[J]. Cell Mol Immunol, 2022 ,19(9):971-992. DOI: 10.1038/s41423-022-00905-x. [40] Zeng C, Wang R, Tan H. Role of pyroptosis in cardiovascular diseases and its therapeutic implications[J]. Int J Biol Sci, 2019 ,15(7):1345-1357. DOI: 10.7150/ijbs.33568. [41] 王佳慧,梁欢,于影,等. 细胞焦亡与心血管疾病的研究进展[J]. 生理学报,2021,73(2):329-341. DOI:10.13294/j.aps.2020.0063. |
[1] |
Wang Zechuan, Huang Yueqin.
Advances in targeted drug therapy for acute myeloid leukemia [J]. International Medicine and Health Guidance News, 2023, 29(8): 1045-1048. |
[2] |
Xu Shijie, Luo Zebin, Chen Xiaodong.
Application and progress of CT pulmonary angiography in diagnosis and treatment of pulmonary embolism [J]. International Medicine and Health Guidance News, 2023, 29(8): 1053-1056. |
[3] |
Zhang Heng, Pan Guangtao, Yin Ming, Zhang Ping, Yin Xia.
Progress in autologous fat transplantation in plastic surgery [J]. International Medicine and Health Guidance News, 2023, 29(7): 889-892. |
[4] |
Cui Jinzhen, Dong Aizhi, Jiang Qianqian, Miao Chunbo, Li Lijuan, Fan Yuguang, Chen Baozeng, Chang Yifang.
Risk factors of late recurrence of atrial fibrillation after radiofrequency ablation [J]. International Medicine and Health Guidance News, 2023, 29(5): 637-642. |
[5] |
Wu Xuemei, Zhang Yujie, Xie Shenghua.
Psoriasis and its cardiovascular system comorbidities [J]. International Medicine and Health Guidance News, 2023, 29(4): 453-456. |
[6] |
Wang Wen, Zhao Xianli, Wu Xubo.
Research progress of high intensity interval training on chronic heart failure [J]. International Medicine and Health Guidance News, 2023, 29(21): 2985-2989. |
[7] |
Chen Jixiang, Lu Jing.
Research progress in optimized adjustment of driving pressure in lung protective ventilation strategies [J]. International Medicine and Health Guidance News, 2023, 29(21): 2990-2994. |
[8] |
Liu Qichang, Yang Qingyu, Zeng Yuping, Gao Dianming, Huang Wenli.
Massage as the main treatment for cervical vertigo [J]. International Medicine and Health Guidance News, 2023, 29(21): 2994-2997. |
[9] |
Wang Yaoyao, Ma Xiufang.
Research progress on immune-mediated inner ear disease [J]. International Medicine and Health Guidance News, 2023, 29(20): 2833-2836. |
[10] |
Wang Lu, Xie Henan, Zhao Qimei, Xie Zheng.
Research progress of assessment tools for adults' oral health literacy assessment [J]. International Medicine and Health Guidance News, 2023, 29(20): 2836-2841. |
[11] |
Chu Linlin, Wang Na, Hao Jiahui, Sun Xiao, Liu Chengxia.
Research progress of polyamines and Helicobacter pylori-induced gastric cancer [J]. International Medicine and Health Guidance News, 2023, 29(20): 2848-2851. |
[12] |
Li Zongrui, Liu Weipeng, Hu Baoguang.
Research progress of NKG2D and its ligands in treatment of gastric cancer [J]. International Medicine and Health Guidance News, 2023, 29(20): 2852-2856. |
[13] |
Yang Lina, Wang Yu, Xia Bo.
Research progress on clinical application of Lao Moxibustion [J]. International Medicine and Health Guidance News, 2023, 29(2): 154-. |
[14] |
Wang Hongchun, Ouyang Dequn.
Efficacy and safety of Yiqi Yangyin Huoxue recipe in treatment of non-valvular atrial fibrillation [J]. International Medicine and Health Guidance News, 2023, 29(2): 187-. |
[15] |
Jiang Qianqian, Cui Jinzhen, Miao Chunbo, Lu Lingyan, Li Lijuan, Fan Yuguang, Chang Yifang, Wang Tao, Dong Aizhi.
Predictive value of neutrophil lymphocyte ratio combined with N-terminal brain natriuretic peptide for early recurrence of persistent atrial fibrillation after radiofrequency ablation [J]. International Medicine and Health Guidance News, 2023, 29(2): 191-. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||